e-learning
resources
Munich 2006
Monday 04.09.2006
Pulmonary arterial hypertension: from bench back to bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension in children with sickle cell disease: how common is it?
R. A. Chaudry, T. Karu, C. Hutchinson, S. Ball, G. Sutherland, A. Bush, M. Rosenthal, S. Crowley (London, United Kingdom)
Source:
Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Session:
Pulmonary arterial hypertension: from bench back to bedside
Session type:
Poster Discussion
Number:
3146
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. A. Chaudry, T. Karu, C. Hutchinson, S. Ball, G. Sutherland, A. Bush, M. Rosenthal, S. Crowley (London, United Kingdom). Pulmonary hypertension in children with sickle cell disease: how common is it?. Eur Respir J 2006; 28: Suppl. 50, 3146
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2011; 39: 3-4
Year: 2012
Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2012; 39: 3-4
Year: 2012
Pulmonary hypertension in the elderly: a different disease?
Source: Breathe 2016; 12: 43-49
Year: 2016
Screening for pulmonary hypertension in sickle cell disease: A regional survey
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Pulmonary function abnormalities in Egyptian sickle cell disease patients
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011
Pulmonary hypertension in sickle cell disease and laboratory markers
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019
Pulmonary arterial hypertension among elderly patients: an emerging problem?
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2012; 39: 112-118
Year: 2012
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2011; 39: 112-118
Year: 2012
Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007
Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005
Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease
Source: Eur Respir J, 52 (4) 1800272; 10.1183/13993003.00272-2018
Year: 2018
Effect of age on pulmonary function in sickle cell disease children
Source: Eur Respir J 2003; 22: Suppl. 45, 130s
Year: 2003
Isolated nocturnal hypoxia in sickle cell disease (SCD)? Is it initial feature or separate entity?
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011
Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011
Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Source: Eur Respir J, 54 (6) 1900585; 10.1183/13993003.00585-2019
Year: 2019
Management of chronic respiratory complications in children and adolescents with sickle cell disease
Source: Eur Respir Rev, 29 (157) 200054; 10.1183/16000617.0054-2020
Year: 2020
Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept